Release
📈 Stocks
Ichnos Glenmark Innovation Files FDA IND Application for ISB 2301
(just now)
Ichnos Glenmark Innovation has filed an IND application with the FDA for its pentaspecific immunocell activator ISB 2301, with a Phase-1 clinical…